Академический Документы
Профессиональный Документы
Культура Документы
Rachel J. Miller MD
Basics
Description
Amenorrhea is the absence of menses. It may be divided into primary and
secondary amenorrhea:
o Primary amenorrhea refers to the absence of menses by age 13 with no
breast development, or by age 15 with normal secondary sexual
development. Or absence of menses 5 years after thelarche.
o
Epidemiology
Amenorrhea affects females during their reproductive years.
The incidence of secondary amenorrhea is 3.3%:
o
Risk Factors
Obesity
Weight loss
Excessive exercise
Chronic disease
Genetics
Amenorrhea can be associated with multiple genetic disorders but, no single
mutation causes it.
See Gonadal dysgenesis; Ovarian Insufficiency/Premature Ovarian Failure
(POF)
Pathophysiology
Normal menstrual function requires an intact hypothalamic-pituitary-ovarianuterine/vaginal axis.
Normally, the hypothalamus releases pulsatile GnRH, which stimulates the
pituitary to release FSH and LH.
Associated Conditions
Multiple, see Differential Diagnosis
Diagnosis
Signs and Symptoms
Absence of menses
History
The patient should be questioned regarding:
Age at thelarche, pubarche, and menarche
Menstrual history
Sexual activity
Pregnancy history
Medication use
Family history:
o
Menarche
Height
Infertility
Physical Exam
Growth pattern
Height and weight (BMI)
Tanner staging
Thyroid exam
External genitalia
Tests
Pregnancy must be evaluated in both primary and secondary amenorrhea.
Labs
Urine or serum -hCG
TSH
Prolactin
If signs of hyperandrogenism:
17-hydroxyprogesterone
FSH
Estradiol
Karyotype
Imaging
Bone age if concern for constitutional delay
Transabdominal pelvic ultrasound to confirm presence of uterus and normal
gonads or evaluate for polycystic ovaries
Hysterosalpingogram
Differential Diagnosis
Infection
Chronic disease or infection
Uterine infectious sequelae
Metabolic/Endocrine
POF:
o
Turner syndrome
Gonadal dysgenesis
Hyperprolactinemia:
Hypothyroidism
Prolactinoma
Medications
Pituitary disease:
o
Hypothalamic dysfunction:
o
Anorexia nervosa
Excessive exercise
Kallmann syndrome
Cushing's disease:
o
Immunologic
Autoimmune premature ovarian failure
Tumor/Malignancy
Prolactinoma
Androgen producing tumors
Trauma
See Sheehan Syndrome.
Drugs
Iatrogenic:
Chemotherapy (i.e., cyclophosphamide)
Radiation therapy
Hormonal contraceptives
Leuprolide
Other/Miscellaneous
Physiologic:
Prepubertal
Menopause
Mllerian agenesis
Imperforate hymen
Cervical stenosis
PCOS
P.3
Management
General Measures
Always treat the underlying etiology.
Weight loss for overweight or obese patients
Special Therapy
Complementary and Alternative Therapies
Healthy, well-balanced diet to achieve normal BMI
Appropriate, moderate exercise to achieve or maintain normal BMI
Medication (Drugs)
Always treat the underlying etiology:
Thyroid replacement if hypothyroid
Dopamine-agonist if hyperprolactinemia
Cyclical estrogen-progesterone
Surgery
Hymenotomy if imperforate hymen
Resection of vaginal septum
Tumor resection
Followup
Disposition
The evaluation of and treatment for amenorrhea is performed in the outpatient setting.
Issues for Referral
Many etiologies for amenorrhea can be managed by the primary care provider.
Conditions that require the help of a specialist may include:
o
Patient Monitoring
Prognosis is based on the underlying etiology.
Many patients will begin or resume menses following therapy for the
underlying condition, especially in cases of endocrine diseases, functional
hypothalamic dysfunction, and PCOS.
Women with PCOS may also have insulin resistance and should be screened
for diabetes.
Bibliography
American College of Obstetrics and Gynecology Committee on Practice BulletinsGynecology. Management of infertility caused by ovulatory dysfunction. Obstet
Gynecol. 2002;99(2):347358.
Mitan LAP. Menstrual dysfunction in anorexia nervosa. J Pediatr Adolesc Gynecol.
2004;17:8185.
Munster K, et al. Secondary amenorrhoea: Prevalence and medical contact: A cross
sectional study from a Danish county. Br J Obstetr Gynecol. 1992;99:430433.
Pettersson F, et al. Epidemiology of secondary amenorrhea: Incidence and prevalence
rates. Am J Obstet Gynecol. 1973;117:8086.
The Practice Committee of the American Society for Reproductive Medicine. Current
evaluation of amenorrhea. Fertil Steril. 2006:86(Suppl 4):S148S155.
Speroff L, et al. Clinical Gynecologic Endocrinology and Infertility, 7th ed. 2004.
Welt CK, et al. Etiology, diagnosis, and treatment of primary amenorrhea. UpToDate
Online 14.3, 2005.
Welt CK, et al. Etiology, diagnosis, and treatment of secondary amenorrhea.
UpToDate Online 14.3, 2005.
Miscellaneous
Clinical Pearls
The most common cause of amenorrhea is pregnancy.
Abbreviations
DHEASDehydroepiandrosterone
FSHFollicle stimulating hormone
GnRHGonadotropin releasing hormone
hCGHuman chorionic gonadotropins
LHLuteinizing hormone
PCOSPolycystic ovarian syndrome
POFPremature ovarian failure
Codes
ICD9-CM
256.8 Amenorrhea (due to ovarian dysfunction)
256.8 Amenorrhea (hyperhormonal)
626.0 Amenorrhea (primary or secondary)
Patient Teaching
Prevention
Amenorrhea may be prevented by:
Treating underlying conditions
Maintaining an appropriate body weight